TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

ASCENTAWITS

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

ASCENTAWITS

ST13

US500000079294237

Classe

5, 35, 41, 42, 44

Pedido

79294237

Registro

6375299

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

27

Atualização mais recente

09/06/2026

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

5, 35, 41, 42, 44

Data de depósito

31/03/2020

Data de registro

08/06/2021

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

08/06/2021

Última transação

09/06/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

5

Tipo de titular

16

Localização do titular

CN

Examinador

LEHKER, DAWN FELDMAN

Unidade examinadora

M20

Localização atual

PUBLICATION AND ISSUE SECTION

Descrição da marca

The mark consists of the word "ASCENTAWITS" in stylized form.

Titulares e representantes

Titulares

ASCENTAWITS PHARMACEUTICALS, LTD.
Ascentawits Pharmaceutical, Ltd.

Representantes

LAURENCE KAO

Classificação técnica

Classes Nice

Classe 5Classe 35Classe 41Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Analgesics; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; chemical reagents for medical or veterinary purposes; biological tissue cultures for medical purposes; reagent paper for medical purposes; diagnostic biomarker reagents for medical purposes; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes

Classe 35

Advertising; online advertising on a computer network; professional business consultancy; sales promotion for others; provision of an online marketplace for buyers and sellers of goods and services; Retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale distributorship services for pharmaceutical, veterinary and sanitary preparations and medical supplies

Classe 41

Education services, namely, training educators in the field of science, technology, engineering and mathematics (STEM) curriculum, teaching methods and providing curricula in connection therewith; education services, namely, training educators to teach through service learning and civic engagement and providing curricula in connection therewith; Educational services, namely, conducting classes, seminars, conferences, workshops, retreats, camps and field trips in the field of pet care, math, tax preparation and distribution of training material in connection therewith; publication of texts, other than publicity texts; publication of books; multimedia publishing of books, magazines, journals, software, games, music, and electronic publications

Classe 42

Research and development of advanced learning technologies and teaching methods; research and development of new products for others; scientific laboratory services; scientific research; medical and scientific research, namely, conducting clinical trials for others

Classe 44

Telemedicine services; preparation of prescriptions by pharmacists; medical, physical rehabilitation and physical therapy services; chemotherapy services; health counseling; palliative care; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical screening

Publicações

Histórico de despachos e eventos da marca no USPTO.

27 publicações encontradas

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

08/06/2026

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

25/10/2021

FICS

FINAL DISPOSITION NOTICE SENT TO IB

23/09/2021

FIMP

FINAL DISPOSITION PROCESSED

23/09/2021

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

08/09/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

08/06/2021

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

30/04/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

23/03/2021

PUBO

PUBLISHED FOR OPPOSITION

23/03/2021

GPNX

NOTIFICATION PROCESSED BY IB

22/03/2021

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

03/03/2021

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

03/03/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/03/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/02/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/02/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

22/11/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

22/11/2020

RFNT

REFUSAL PROCESSED BY IB

22/11/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

02/11/2020

RFRR

REFUSAL PROCESSED BY MPU

02/11/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

10/10/2020

CNRT

NON-FINAL ACTION WRITTEN

09/10/2020

MAFR

APPLICATION FILING RECEIPT MAILED

06/10/2020

DOCK

ASSIGNED TO EXAMINER

30/09/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

30/09/2020

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

29/09/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

24/09/2020

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace ASCENTAWITS ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.